Trial intelligence / Profile preview

Intranasal Calcitonin for Pain in Elderly Pelvic Ring Fractures

NCT03812991Phase 4Completed

Sponsor
University of Missouri
Start
Jul 2019
Primary completion
Sep 2022
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, randomised, open-label trial of calcitonin salmon in pelvic ring fracture (2 arms), sponsored by University of Missouri. Primary endpoint: Visual Analogue Scale at 3 months. Started Jul 2019; status: completed.

02

Drugs

calcitonin salmon
03

Conditions

pelvic ring fracture

Beyond the preview

Go deeper on NCT03812991.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03812991.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call